Research graph
References from Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41586-018-0024-3
10.1038/s41586-018-0024-3 · External reference
10.1016/j.semcancer.2018.05.002
10.1016/j.semcancer.2018.05.002 · External reference
10.1016/j.canlet.2015.07.039
10.1016/j.canlet.2015.07.039 · External reference
10.1016/s0140-6736(18)30789-x
10.1016/s0140-6736(18)30789-x · External reference
No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
10.1080/2162402x.2020.1826132 · 2020 · External reference
10.1016/j.ebiom.2019.03.043
10.1016/j.ebiom.2019.03.043 · External reference
10.1111/jcmm.14999
10.1111/jcmm.14999 · External reference
10.1007/s00262-020-02801-7
10.1007/s00262-020-02801-7 · External reference
10.1002/bjs.10871
10.1002/bjs.10871 · External reference
10.1007/s00262-018-2289-7
10.1007/s00262-018-2289-7 · External reference
Comprehensive analyses reveal TKI-induced remodeling of the tumor immune microenvironment in EGFR/ALK-positive non-small-cell lung cancer
10.1080/2162402x.2021.1951019 · 2021 · External reference
CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy
10.1038/s41388-021-01932-0 · 2021 · External reference
10.1038/nature21349
10.1038/nature21349 · External reference
Unresolved reference
External reference
10.1038/nature25501
10.1038/nature25501 · External reference
10.1016/j.trecan.2017.01.001
10.1016/j.trecan.2017.01.001 · External reference
10.1080/15592294.2016.1265711
10.1080/15592294.2016.1265711 · External reference
10.1073/pnas.0804063105
10.1073/pnas.0804063105 · External reference
10.1074/jbc.m401907200
10.1074/jbc.m401907200 · External reference
10.1016/j.annonc.2020.06.022
10.1016/j.annonc.2020.06.022 · External reference
10.1056/nejmoa022289
10.1056/nejmoa022289 · External reference
10.1038/nm.3967
10.1038/nm.3967 · External reference
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
10.1038/nm.3175 · 2013 · External reference
10.1038/nm.3174
10.1038/nm.3174 · External reference
Clinical outcome from oxaliplatin treatment in stage II/III colon cancer according to intrinsic subtypes: secondary analysis of NSABP C-07/NRG oncology randomized clinical trial
10.1001/jamaoncol.2016.2314 · 2016 · External reference
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer
10.1016/j.ygyno.2012.04.006 · 2012 · External reference
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
10.1016/j.ejca.2019.07.022 · 2019 · External reference
Defects in DNA repair genes confer improved long-term survival after cisplatin-based neoadjuvant chemotherapy for muscle-invasive bladder cancer
10.1016/j.euo.2020.02.003 · 2020 · External reference
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer
10.21037/jgo.2019.09.12 · 2019 · External reference
10.1186/s13148-021-01154-x
10.1186/s13148-021-01154-x · External reference
Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer
10.1016/j.bcp.2020.114365 · 2021 · External reference
10.1021/acs.jmedchem.6b01243
10.1021/acs.jmedchem.6b01243 · External reference
Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma
2008 · External reference
